+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 70Years
All Genders
ID07412470

Study Evaluating Frexalimab Compared to Tacrolimus for Adults Receiving First Kidney Transplant Randomized, Open-Label Trial Assessing Long-Term Safety and Efficacy Sponsored by Sanofi

Led by Sanofi · Updated on 2026-10-13

526

Participants Needed

73

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of frexalimab compared to tacrolimus in adults undergoing their first kidney transplant who have a low to moderate risk of organ rejection. This open-label, randomized study will span up to approximately 5 years, aiming to understand how these treatments perform in kidney transplant recipients. The study is sponsored by Sanofi and involves adults aged 18 to 70 years. Participants will receive either frexalimab or tacrolimus as part of their immunosuppressive therapy. The initial dose of frexalimab is given intravenously, followed by subcutaneous doses administered using an on-body delivery system. Tacrolimus is given orally as capsules. The study includes about 38 visits over the treatment period, which may extend up to 5 years. During the study, participants will be regularly monitored through various assessments including kidney function tests, measurement of rejection episodes, antibody levels, and side effects related to immunosuppressive therapy. Researchers will track outcomes such as graft survival, participant survival, kidney filtration rates, and cardiovascular events over time. Safety and drug levels will also be closely observed throughout the study duration.

CONDITIONS

Brief Title

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

Research Team

T

Trial Transparency email recommended (Toll free for US & Canada)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here